alopecia areata

Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to alopecia areata: alopecia totalis, alopecia universalis
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to alopecia areata

patchy baldness

Related Words

References in periodicals archive ?
There are several uncontrolled studies of PUVA for alopecia areata using all type of PUVA (oral or topical psoralen, local or whole-body UVA irradiation.
The open label trial (NCT03811912) is a randomised, multi-center study to evaluate the efficacy and tolerability of once-daily versus twice-daily dosing of CTP-543, in 57 adult patients with chronic, moderate-to-severe alopecia areata. Patients in the trial were randomized to receive CTP-543 either 8 mg twice-daily or 16 mg once-daily over a 24 week treatment period.
The results of these studies do offer new hope for Alopecia areata patients and promise a new evidence-based therapy for this frustrating disease process.
"My personal view is that these results represent a paradigm shift in the treatment of alopecia areata. Perhaps a line in the sand.
He was diagnosed as multifocal alopecia areata, lichen planus and vitiligo vulgaris with isotopic phenomenon of vitiligo occurring over lichenoid lesions.
They identified inpatients with alopecia areata based on the ICD-9-CM code and compared them to all patients without the condition.
The key immune cells in alopecia areata are the same cells that many cancers can evade, but the killer T cells are crucial for the success of cancer immunotherapies.
There are many barriers that stand in the way of getting you and the patient on the same side of the issue of dealing with severe alopecia areata. The high emotional content of the discussion can be big factor, not just for the patient and family members but also for you.
No matter how concerning the alopecia areata is to this 20-year-old man, it's just another hair loss case for me.
Noha Nabil Doghaim, M.D., from Tanta University in Egypt, and colleagues randomized 40 patients with alopecia areata and 40 patients with androgenetic alopecia to receive either carboxytherapy or placebo.
Alopecia areata is a chronic disease that affects hair follicles.
The research could lead to new treatments for alopecia areata - an autoimmune disease that causes patchy hair loss from the scalp and eyebrows - or even male-pattern baldness.
As a result of this transaction, Aclaris acquired worldwide rights to intellectual property licensed to Vixen by Columbia University covering the use of certain Janus Kinase inhibitor compounds for the treatment of alopecia areata, androgenetic alopecia and other dermatological conditions.